Versicor brought to the table a host of interesting programs early in the research pipeline and an antifungal drug, anidulafungin, which is now being evaluated by the FDA to treat invasive fungal infections that can damage the internal organs of patients with already compromised immune systems.

FORBES: Building An Antibiotic Powerhouse

Last week, on the 40th Anniversary of Earth Day, I found myself in an interesting discussion with business leaders in one of our Executive Education programs at Thunderbird School of Global Management, focused on the roles of business and government in creating not only a livable and sustainable environment, but a stable and predictable society.

FORBES: Environmental Regulations: The New Frontier

Croissance Plus, the association for entrepreneurs in France, took an interesting view on the jobs programs.

FORBES: Mind the Geese

Will the dearth of interesting unpartnered Phase 2-3 programs that exists today begin to shift backward in development as earlier deals are being done?

FORBES: Preclinical Biotech Structured Deals: Reflections on 2013's Solid Start